Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
35
HLOSF Quote, Financials, Valuation and Earnings
Last price:
$1.35
Seasonality move
:
-23.39%
Day range:
$1.35 - $1.35
52-week range:
$0.93 - $1.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
32.00x
P/B ratio:
6.04x
Volume:
--
Avg. volume:
315
1-year change:
-14.83%
Market cap:
$121.7M
Revenue:
$862.4K
EPS (TTM):
-$0.47
Analysts' Opinion
-
Consensus RatingHealios KK has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Healios KK has an estimated downside of -- from its current price of $1.35.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $1.35.
Fair Value
-
According to the consensus of 0 analysts, Healios KK has -- downside to fair value with a price target of -- per share.
HLOSF vs. S&P 500
-
Over the past 5 trading days, Healios KK has underperformed the S&P 500 by -1.77% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Healios KK does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Healios KK has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Healios KK reported revenues of $3.2M.
Earnings Growth
-
Healios KK has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Healios KK reported earnings per share of -$0.04.
Enterprise value:
104.1M
EV / Invested capital:
--
Price / LTM sales:
32.00x
EV / EBIT:
--
EV / Revenue:
31.00x
PEG ratio (5yr expected):
-0.14x
EV / Free cash flow:
-5.05x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.9M
Return On Assets:
-33.1%
Net Income Margin (TTM):
-1081.88%
Return On Equity:
-137.21%
Return On Invested Capital:
-55.94%
Operating Margin:
-56.63%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $376.3K | $1.3M | $3.4M | $728.8K | $3.2M | |
| Gross Profit | $376.3K | $1.2M | $2.9M | $641.3K | $2.8M | |
| Operating Income | -$51.2M | -$26.7M | -$21.4M | -$4.9M | -$1.8M | |
| EBITDA | -$37.5M | -$19.9M | -$15.7M | -$3.3M | -$320.7K | |
| Diluted EPS | -$1.04 | -$0.39 | -$0.47 | -$0.08 | -$0.04 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $152.7M | $109.7M | $98.8M | $53.9M | $61.3M | |
| Total Assets | $245.3M | $182.8M | $152M | $101.5M | $110.7M | |
| Current Liabilities | $35.8M | $13.9M | $45.4M | $24M | $44.2M | |
| Total Liabilities | $136.2M | $131.2M | $119.3M | $79M | $90.4M | |
| Total Equity | $109.1M | $51.6M | $32.7M | $22.5M | $20.3M | |
| Total Debt | $95.8M | $102.2M | $86.5M | $47.8M | $37.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$46.3M | -$24M | -$18.7M | -$3.4M | -$2.9M | |
| Cash From Investing | -$8.1M | -$4.8M | -$8.2M | $202.4K | -$1.2M | |
| Cash From Financing | $66.2M | -$12.2M | $38.4M | $946K | $8.7M | |
| Free Cash Flow | -$48.5M | -$24.7M | -$20.6M | -$3.5M | -$4.8M | |
HLOSF
Sector
Market Cap
$121.7M
$46.5M
Price % of 52-Week High
78.04%
47.23%
Dividend Yield
0%
0%
Shareholder Yield
-29.82%
-0.6%
1-Year Price Total Return
-14.83%
-31.38%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$1.35
200-day SMA
Buy
Level
$1.26
Bollinger Bands (100)
Sell
Level
1.27 - 1.67
Chaikin Money Flow
Sell
Level
-2.4K
20-day SMA
Buy
Level
$1.34
Relative Strength Index (RSI14)
Sell
Level
45.52
ADX Line
Neutral
Level
Williams %R
Sell
Level
0
50-day SMA
Sell
Level
$1.40
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Sell
Level
-1.3K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-2.3479)
Buy
Beneish M-Score
(Annual)
Level (-2.4113)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (4.2434)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products. The company is developing treatments for age-related macular degeneration and organ anlage transplantation therapy.
Stock Forecast FAQ
In the current month, HLOSF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HLOSF average analyst price target in the past 3 months is --.
-
Where Will Healios KK Stock Be In 1 Year?
According to analysts, the consensus estimate is that Healios KK share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Healios KK?
Analysts are divided on their view about Healios KK share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Healios KK is a Sell and believe this share price will rise from its current level to --.
-
What Is Healios KK's Price Target?
The price target for Healios KK over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HLOSF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Healios KK is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HLOSF?
You can purchase shares of Healios KK via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Healios KK shares.
-
What Is The Healios KK Share Price Today?
Healios KK was last trading at $1.35 per share. This represents the most recent stock quote for Healios KK. Yesterday, Healios KK closed at $1.35 per share.
-
How To Buy Healios KK Stock Online?
In order to purchase Healios KK stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 7.51% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 1.75% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 3.32% over the past day.
